A bill for an act relating to the issuance of medical cannabidiol registration cards and licensure of medical cannabidiol dispensaries. (Formerly HSB 224.) Effective date: 07/01/2026.
Summary
HF 990 amends Iowa’s medical cannabidiol law, primarily by updating the rules for medical cannabidiol registration cards and dispensary licensing. The bill removes a prior paragraph in section 124E.4, revises the information required on patient registration materials, and changes the department’s authority and process for licensing dispensaries. It also updates the statutory language so the department must accept applications to select and license dispensaries, may license up to ten dispensaries, and must license new dispensaries or relicense existing ones by December 1 each year.
In practical terms, the bill modernizes and streamlines parts of Iowa’s medical cannabis administrative framework. It affects the Iowa Department of Health and Human Services’ oversight of patient registration cards and dispensary licensing, and it may expand or stabilize the number of dispensaries operating in the state by allowing up to ten licenses and requiring annual relicensing. The bill is effective July 1, 2026, and became Acts Chapter 1166.
Impact
The bill amends Iowa Code chapter 124E governing medical cannabidiol by changing patient registration card requirements and revising dispensary licensing procedures. It removes one registration-card requirement, simplifies the patient information provisions, and replaces older language about an initial request-for-proposals process with ongoing application and licensing authority. The bill also authorizes licensing of up to ten medical cannabidiol dispensaries and requires annual licensing or relicensing, directly affecting the state agency that administers the program, dispensary operators, and qualifying patients who rely on the program.
Sentiment
The overall sentiment appears strongly favorable. The bill passed the House and Senate with substantial bipartisan support, including large margins on final passage and committee approval in the Senate Commerce report. The voting pattern suggests broad agreement that the medical cannabidiol program should be updated and administered more flexibly, with no evidence of major opposition in the available materials.
Contention
The main points of contention appear to have been limited and procedural rather than ideological. The only recorded dissent came from a small number of legislators in each vote, suggesting that any concerns were likely about the scope of dispensary licensing, the regulatory structure, or the details of patient registration requirements rather than the existence of the medical cannabidiol program itself. Because no committee transcripts are available, the record does not show any specific debated issues beyond the statutory changes to licensing and registration.
A bill for an act relating to medical cannabidiol by providing deductions from the individual and corporate income taxes for expenses incurred by medical cannabidiol manufacturers and dispensaries, and including retroactive applicability provisions.